CDHO Advisory: Dementia
COLLEGE OF DENTAL HYGIENISTS OF ONTARIO ADVISORY
ADVISORY TITLE
Use of the dental hygiene interventions of scaling of teeth and root planing including curetting surrounding tissue, orthodontic and restorative practices, and other invasive interventions for persons1 with dementia.
ADVISORY STATUS
Cite as College of Dental Hygienists of Ontario, CDHO Advisory Dementia, 2024-06-26
INTERVENTIONS AND PRACTICES CONSIDERED
Scaling of teeth and root planing including curetting surrounding tissue, orthodontic and restorative practices, and other invasive interventions (“the Procedures”).
SCOPE
DISEASE/CONDITION(S)/PROCEDURE(S)
Dementia
INTENDED USERS
Advanced practice nurses
Dental assistants
Dental hygienists
Dentists
Denturists
Dieticians
Health professional students
Nurses
Patients/clients
Pharmacists
Physicians
Public health departments
Regulatory bodies
ADVISORY OBJECTIVE(S)
To guide dental hygienists at the point of care relative to the use of the Procedures for persons who have dementia, chiefly as follows.
- Understanding the medical condition.
- Sourcing medications information.
- Taking the medical and medications history.
- Identifying and contacting the most appropriate healthcare provider(s) for medical advice.
- Understanding and taking appropriate precautions prior to and during the Procedures proposed.
- Deciding when and when not to proceed with the Procedures proposed.
- Dealing with adverse events arising during the Procedures.
- Keeping records.
- Advising the patient/client.
TARGET POPULATION
Middle Age (45 to 64 years)
Aged (65 to 79 years)
Aged 80 and over
Male
Female
Parents, guardians, and family caregivers of children, young persons and adults with dementia.
MAJOR OUTCOMES CONSIDERED
For persons who have dementia: to maximize health benefits and minimize adverse effects by promoting the performance of the Procedures at the right time with the appropriate precautions, and by discouraging the performance of the Procedures at the wrong time or in the absence of appropriate precautions.
RECOMMENDATIONS
UNDERSTANDING THE MEDICAL CONDITION
Terminology used in this Advisory
Resources consulted
- Alzheimer’s disease: Alzheimer Society Canada
- Centre for Addiction and Mental Health
- Vascular Dementia: Alzheimer Society Canada
- Alzheimer’s Disease: Canadian Mental Health Association, British Columbia Division
Dementia is a set of symptoms and signs associated with changes in particular parts of the brain, which
- is characterized chiefly by
- loss of memory
- impairment of judgment and reasoning
- changes in thinking, mood, and behaviour
- loss of communication abilities.
- occurs as disorders which manifest the symptoms of dementia, chiefly
- Alzheimer disease, the most common dementia-related condition, of two types
- sporadic Alzheimer disease
- familial Alzheimer disease
- Creutzfeldt-Jakob disease
- frontotemporal dementia
- Lewy body dementia
- vascular dementia, the second most common dementia-related condition.
- Alzheimer disease, the most common dementia-related condition, of two types
Overview of dementia
Resources consulted
- College of Dental Hygienists of Ontario: Dementia Fact Sheet
- A Dementia Strategy for Canada: Together We Aspire: Government of Canada
- Alzheimer’s disease: Alzheimer Society Canada
- Alzheimer’s disease: MedlinePlus
- Approach to management of mild to moderate dementia, Canadian guidelines: Canadian Medical Association Journal
- Dementia: MedlinePlus
- Frontotemporal Lobe Dementia: Medscape
- Including Persons With Alzheimer Disease in Research on Comorbid Conditions: Comorbid Medical Conditions: Medscape
- Lewy body dementia: Alzheimer Society Canada
- Frontotemporal dementia: MedlinePlus
- Alzheimer’s Disease: Canadian Mental Health Association, British Columbia Division
- Vascular Dementia: Alzheimer Society Canada
- Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia: Alzheimer’s & Dementia Journal
Dementia
- describes a set of signs and symptoms arising from loss of brain function, that
- in most dementia-related conditions
- is nonreversible
- cannot be cured or slowed in its progression
- most commonly manifests as Alzheimer’s disease
- may be a comorbidity, complication or associated condition of other brain disorders.
- in most dementia-related conditions
- occurs in
- 7 percent of Canadians over the age of 60 years
- 50 percent of seniors aged 90 years and over.
- results from particular causes or is associated with risk factors that
- include
- amyotrophic lateral sclerosis (CDHO Advisory)
- Huntington’s disease
- infections of the brain, such as
- HIV/AIDS (CDHO Advisory)
- Lyme disease
- many small strokes
- multiple sclerosis (CDHO Advisory)
- Parkinson’s disease (CDHO Advisory)
- frontotemporal dementia (Pick’s disease)
- progressive supranuclear palsy
- also include causes or risk factors that may be stopped or reversed if they are found soon enough, such as
- anemia (CDHO Advisory)
- brain tumours (CDHO Advisory)
- chronic alcohol abuse (CDHO Advisory)
- depression (CDHO Advisory)
- low vitamin B12 levels (CDHO Advisory)
- Lyme disease
- medication side effects
- metabolic causes
- normal-pressure hydrocephalus
- age, because
- the risk of dementia rises with age
- dementia is rare under age 60.
- include
- presents signs and symptoms that include
- difficulty with mental functions, including
- cognitive skills, such as
- abstract thinking
- calculation
- judgment
- emotion
- behaviour
- expression of personality
- language
- memory
- perception
- cognitive skills, such as
- pain, which may be directly related to comorbidities, complications and associated conditions, which
- may not be recognized, assessed or treated effectively
- because elderly persons with dementia differ from elderly persons without dementia in the ways they
- perceive or experience pain
- describe, express or signal pain which persons with dementia may through behaviours
- such as rocking or striking out
- which may be wrongly attributed to dementia
- which may result in common, painful conditions, such as mouth ulcers, remaining undetected
- because elderly persons with dementia differ from elderly persons without dementia in the ways they
- requires professional service providers, such as dental hygienists, and family caregivers to understand
- when an elderly person is experiencing pain
- when treatment is required
- requires for the patient/clients
- necessary investigation and care regardless of mental status
- coordination of medications used for pain management
- may not be recognized, assessed or treated effectively
- mild cognitive impairment as the initial appearance, which
- is the stage between normal forgetfulness due to aging and the development of dementia
- is characterized by mild problems with thinking and memory that
- do not interfere with everyday activities
- are apparent to the person
- does not invariably develop into a dementia-related condition
- difficulties manifested as
- general categories of challenges, such as
- difficulty in performing more than one task at a time
- difficulty in solving problems
- forgetting of recent events or conversations
- requiring extra time in performing somewhat complex mental activities
- specific problems, such as
- difficulty in naming familiar objects
- misplacing things
- getting lost on familiar routes
- impairment of social skills
- undergoing personality changes
- losing interest in things previously enjoyed
- flat mood
- difficulty performing tasks such as
- balancing a checkbook
- playing card games
- learning new information or routines
- general categories of challenges, such as
- increasing interference with life and self-care through
- forgetfulness of
- details of current events
- events in the person’s own life history
- social withdrawal
- loss of self-awareness
- nocturnal wakefulness
- major difficulty reading or writing
- impairment of
- judgment
- ability to recognize danger
- word confusion, pronunciation difficulty, muddle in spoken sentences
- hallucinations, argumentativeness, threatening and violent behaviour
- delusions, depression, and agitation
- difficulty with basic tasks, such as preparing meals, choosing proper clothing, and driving
- forgetfulness of
- late-stage loss of ability to
- understand language
- recognize family members
- perform basic activities of daily living, such as eating, dressing, and bathing
- physical manifestations, such as
- incontinence
- swallowing difficulties.
- difficulty with mental functions, including
- is clinically investigated by tests
- of mental status
- for causes that can be arrested.
- is treated with regimens that
- aim to control symptoms
- focus on the causal condition if one can be recognized
- may involve short or long-term residential or institutional care
- require caution in altering medications, because some changes may increase confusion
- involve mental stimulation and attention to quality of life of the person and of family caregiver
- address comorbid conditions, complications and associated conditions which adversely affect mental function, such as
- anemia (CDHO Advisory)
- decreased oxygenation of the blood
- depression (CDHO Advisory)
- heart failure (CDHO Advisory)
- infections
- nutritional disorders (CDHO Advisory)
- thyroid disorders (CDHO Advisory), (CDHO Advisory)
- anemia (CDHO Advisory)
- decreased oxygenation of the blood
- depression (CDHO Advisory)
- heart failure (CDHO Advisory)
- infections
- nutritional disorders (CDHO Advisory)
- thyroid disorders (CDHO Advisory), (CDHO Advisory)
- use medications
- include regular checks of
- vision
- hearing
- increasingly involve communal and inclusive activities, such as
- dancing
- familiar activities appealing to the person
- do not normally involve psychotherapy or group therapy because these may increase rather than decrease confusion.
- can be prevented only to a limited extent
- chiefly through life-style changes to prevent vascular dementia
- because most types of dementia are not preventable.
- offers a variable prognosis because dementia
- may not always develop from mild cognitive impairment
- when it does develop, it usually
- progresses
- diminishes the quality of life
- decreases lifespan.
- generates complex social considerations which
- become pressing when
- dementia develops
- a sudden change in mental status occurs
- the mental condition of a person worsens
- the family caregiver is unable to care for the person at home
- raise difficult ethical questions, such as the patient/client’s
- decision-making capacity for giving consent for
- the Procedures
- disclosure of personal health information
- vulnerability socially, mentally, physically and financially
- decision-making capacity for giving consent for
- often require involvement of support groups, such as in
- become pressing when
- occurs chiefly as the following disorders
- Alzheimer disease (AD)
- was first identified in 1906 by Dr Alois Alzheimer, who described
- numerous dense microscopic deposits, plaques, scattered throughout the brain which when excessive harm brain cells
- tangles, which interfere with the brain’s physiological processes and eventually choke off the living cells
- is the most common dementia-related condition
- is of two types
- sporadic Alzheimer disease, which
- accounts for more than 90 percent of diagnoses of Alzheimer disease
- may affect adult men and women of all ages though mostly occurs in persons over the age of 65 years
- may take up to 20 years to develop
- familial Alzheimer disease, which
- account for fewer than 10 percent of diagnoses of Alzheimer disease
- is caused by a genetic mutation
- begins in the age range of 40 to 50 years
- sporadic Alzheimer disease, which
- accounts for about 64 percent of all dementia-related conditions diagnosed in Canada
- is a progressive, degenerative disease of the brain
- characterized by deterioration of thinking ability and memory
- caused by progressive death of brain cells
- is marked by shrinking of some parts of the brain following degeneration and death of brain cells
- is associated with Down syndrome (CDHO Advisory) which, as aging progresses, leads to the types of changes in the brain observed in Alzheimer disease, though not all persons with Down syndrome develop it
- presents as
- gradual onset and continuing decline of memory
- changes in judgment and reasoning
- loss of ability to perform familiar tasks
- affects all aspects of a person’s life: thinking, feeling and acting
- varies widely in its impact on individuals, making unpredictable the
- effects experienced
- order in which the effects appear
- rate of progression
- involves impairment of
- mental abilities
- to understand, think, remember and communicate
- to make decisions; simple tasks performed for years become more difficult or are forgotten
- to find the right words and follow a conversation
- to recall recent events and ultimately events in the distant past, reflective of memory loss and confusion
- emotions and moods, revealed as
- uninterested, apathetic and withdrawn demeanour
- diminished expressiveness
- loss of interest in hobbies and activities previously enjoyed
- loss of ability to control mood and emotion, though it seems that even in the later stages of the disease the person may continue to experience joy, anger, fear, love, and sadness
- behaviour, in the form of
- changes observed in the person’s reactions to surroundings
- actions that seem out of character
- repetitiveness of
- actions or words, statements and questions
- hiding of possessions
- physical outbursts and restlessness
- physical abilities manifested as
- loss of physical co-ordination and mobility, leading to gradual physical decline
- deterioration in the performance of day-to-day tasks of self-care such as eating, bathing, getting dressed and oral hygiene.
- mental abilities
- was first identified in 1906 by Dr Alois Alzheimer, who described
- Creutzfeldt-Jakob disease (CJD)
- is a rare, rapidly fatal disease of the type spongiform encephalopathy believed to be caused by abnormal proteins called prions
- occurs in various forms, including sporadic (90 percent of CJD), genetic mutation (10 percent of CJD), and transmitted (very rare)
- occurs in animals; for example, in cattle as bovine spongiform encephalopathy known also as “Mad Cow” disease.
- Lewy body dementia
- is characterized by abnormal deposits of a protein, called Lewy bodies, that form inside the nerve cells of the brain
- chiefly affects the areas of the brain involved in thinking and movement
- is of unknown cause
- accounts for 15 to 20 percent of all dementias diagnosed
- occurs alone or in conjunction with
- Alzheimer disease
- Parkinson’s disease (CDHO Advisory).
- Frontotemporal dementia
- includes subtype known as Pick disease
- comprises a group of rare disorders primarily affecting the frontal and temporal lobes of the brain, the areas generally associated with personality and behaviour
- include types in which brain cells
- in the areas shrink or die
- enlarge and contain round Pick’s bodies
- accounts for some 2 percent of dementia-related conditions.
- Vascular dementia, the second most common type of dementia-related condition (20 percent of all diagnosed dementias), which
- occurs when the cells in the brain die because they are deprived of oxygen
- is commonly caused by many small strokes
- occurs less commonly as Binswanger’s disease, which is
- caused by atherosclerosis in the brain’s white matter
- associated with hypertension.
- Alzheimer disease (AD)
Multimedia and images
Alzheimer disease
Alzheimer disease, video
Comorbidity, complications and associated conditions
Comorbid conditions are those which co-exist with dementia but which are not believed to be caused by it. Complications and associated conditions are those that may have some link with it. Distinguishing among comorbid conditions, complications and associated conditions may be difficult in clinical practice.
Comorbidities, complications and associated conditions of dementia include the following categories.
- Antecedents
- alcoholism
- brain injury
- drug abuse
- side effects of certain medications
- thyroid function abnormalities
- vitamin B12 deficiency.
- Circumstances
- abuse by a caregiver
- malnutrition because of
- the person’s confusion
- inadequacy of care for the person
- infection because of inadequate care or self-care
- side-effects of treatments including
- medications
- inappropriate care
- constipation.
- Consequences
- loss of ability to
- function unaided
- care for self
- to interact with family, friends and caregivers
- impairment of the quality of life of the person with dementia, the family and the family caregiver, associated with the person’s
- apathy
- depression
- anxiety
- physical injury, such as hip fracture
- pain, dyspnea, agitation, depression, and other symptoms which could be associated with a comorbidity, complications and associated conditions of dementia rather than the dementia itself
- development of chronic conditions requiring medical care, and which contribute more to mortality than the dementia itself such as
- cardiovascular disease
- congestive heart failure
- coronary artery disease
- ischemic heart disease
- chronic obstructive pulmonary disease
- diabetes
- genitourinary disorders
- cardiovascular disease
- in the late stages, requirement for palliative, hospice or residential care
- reduced lifespan.
- loss of ability to
Oral health considerations
Resources consulted
- College of Dental Hygienists of Ontario: Dementia Fact Sheet
- Approach to management of mild to moderate dementia, Canadian guidelines: Canadian Medical Association Journal
- Dental care and dementia: Alzheimer’s Society
- Dental Care: Alzheimer Society Canada
- Dental surgery attendance amongst patients with moderately advanced dementia attending a day unit: a survey of carers’ views: British Dental Journal
- Personal Care: Alzheimer Society Canada
- Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia: Alzheimer’s & Dementia Journal
The dental hygienist is an important service provider in the care of persons with dementia because appropriate oral healthcare
- is necessary in light of findings that poor oral hygiene is more common in dementia compared with age-matched controls, a gap in health status which is attributed to
- deterioration in self-care
- diminished ability to adapt to changes such as new dentures.
- is important to prevent tooth decay and gum disease, which may diminish the patient/client’s ability and willingness to eat.
- calls for oral assessment
- early in the development of dementia
- focused on retention of natural teeth.
- requires consideration of the role of the family caregiver because
- for the care of persons with mild-to-moderate dementia, the traditional model of chronic disease management is shifting from reliance on self-management by the person to greater involvement of the family caregiver, a change which
- increases the care load and associated burdens of responsibility for family caregivers
- the care load and associated burdens on families and family caregivers may actually increase when the person is transferred to facility-based care
- family or other caregivers may be reluctant to accompany a dementia patient/client for oral healthcare because of
- anxiety that the patient/client be uncooperative
- concerns that the patient/client may become upset
- en route to the oral healthcare office
- by the presence of an oral healthcare professional in the patient/client’s home or place of residence
- inadequate preparation for the oral healthcare visit, for example by omission of reassurances that even patients/clients with advanced dementia may be able to co-operate with oral healthcare because appropriate behaviours learned in childhood may be retained
- of concerns that oral healthcare may not be sufficiently beneficial to justify risk of provoking behavioural problems.
- for the care of persons with mild-to-moderate dementia, the traditional model of chronic disease management is shifting from reliance on self-management by the person to greater involvement of the family caregiver, a change which
- requires communication with the family caregiver because the patient/client may be unable to
- recall important aspects of his or her medical history
- describe symptoms accurately
- remember appointments.
- should be closely integrated with the person’s care generally because
- in the early stages of dementia the patient/client may be capable of oral self-care but nevertheless may
- need reminding, supervision or help
- be assisted with an electric toothbrush or a toothbrush with a grip-enhancing adaptation
- in the later stages of dementia, when self-care skills and interest in most aspects of self-care diminishes, the patient/client may
- lose the ability for cleaning teeth
- lose interest in oral self-care
- need family or other care providers to take over, who themselves require guidance on technique
- may require adequate sedation for the Procedures.
- in the early stages of dementia the patient/client may be capable of oral self-care but nevertheless may
- requires mouth checks as the person/client’s ability to describe or report oral symptoms, including pain, diminishes with progression of dementia; such checks should include
- inspection for
- injury from biting and other trauma
- signs of oral cancer
- enquiry of family caregiver for signs such as
- rubbing or touching the cheek or jaw
- moaning or shouting
- head rolling or nodding
- flinching when washing the face or being shaved
- refusing hot or cold food or drinks
- restlessness, poor sleep, increased irritation or aggression
- refusal or reluctance to use dentures not previously a problem.
- inspection for
- involves review of the oral side effects of medications taken by the patient/client.
MEDICATIONS SUMMARY
Sourcing medications information
- Adverse effect database
- Health Canada’s Marketed Health Products Directorate (MedEffect Canada) toll-free 1-866-234-2345
- Health Canada’s Drug Product Database
- Specialized organizations
- Articles/Guidelines
- Medications considerations
All medications have potential side effects whether taken alone or in combination with other prescription medications, or as over-the-counter (OTC) or herbal medications. - Information on herbals and supplements
- Complementary and alternative medicine
Types of medications
Medications
- cannot halt or reverse brain damage in dementia generally or Alzheimer’s disease specifically.
- are generally used to
- relieve symptoms and possibly delay their appearance
- control behaviour problems caused by a loss of judgment, increased impulsivity, and confusion
- slow the rate at which symptoms worsen.
- are supplemented by medication treatments for comorbidities, complications and associated conditions.
- include
- antipsychotics (for behavioural problems)
haloperidol (no brand name products)
olanzapine (Zyprexa®)
risperidone (Risperdal®) - mood stabilizers
citalopram (Celexa®)
fluoxetine (Prozac®, Rapiflux®, Sarafem®, Selfemra®)
imipramine (Tofranil®) - anti-anxiety and anti-depression medications
buspirone (BuSpar®)
trazodone (Oleptro®) - tranquillizers
alprazolam (Alprazolam Intensol, Xanax®)
diazepam (Valium®) - stimulants
methylphenidate (Concerta®, Methylin®, Metadate®, Ritalin®) - cholinesterase inhibitors specifically intended for treatment of dementia, which increase the levels of or enhance the effectiveness of acetylcholine, a chemical messenger in the brain
donepezil (Aricept®)
galantamine (Razadyne®, formerly called Reminyl®)
rivastigmine (Exelon®) - monoclonal antibody medications for the treatment of Alzheimer disease
aducanumab (Aduhelm®)2
lecanemab (Leqembi®)3 - NMDA4 receptor antagonists specifically intended for treatment of dementia
memantine (Ebixa®, Namenda®).
- antipsychotics (for behavioural problems)
Side effects of medications
See the links above to the specific medications.
THE MEDICAL AND MEDICATIONS HISTORY
The dental hygienist in taking the medical and medications history-taking should
- focus on screening the patient/client prior to treatment decision relative to
- key symptoms
- medications considerations
- contraindications
- complications
- comorbidities
- associated conditions.
- explore the need for advice from the primary or specialized care provider(s).
- inquire about
- the patient/client’s understanding and acceptance of the need for oral healthcare
- symptoms indicative of inadequate emotional moods and behavioural changes likely to adversely affect oral healthcare
- medications considerations, including over-the-counter medications, herbals and supplements
- problems with previous dental/dental hygiene care
- problems with infections generally and specifically associated with dental/dental hygiene care
- the patient/client’s current state of health
- how the patient/client’s current symptoms relate to
- oral health
- health generally
- recent changes in the patient/client’s condition.
IDENTIFYING AND CONTACTING THE MOST APPROPRIATE HEALTHCARE PROVIDER(S) FOR ADVICE
Identifying and contacting the most appropriate healthcare provider(s) from whom to obtain medical or other advice pertinent to a particular patient/client
The dental hygienist should
- record the name of the physician/primary care provider most closely associated with the patient/client’s healthcare, and the telephone number
- obtain from the patient/client or parent/guardian written, informed consent to contact the identified physician/primary healthcare provider
- use a consent/medical consultation form, and be prepared to securely send the form to the provider
- include on the form a standardized statement of the Procedures proposed, with a request for advice on proceeding or not at the particular time, and any precautions to be observed.
UNDERSTANDING AND TAKING APPROPRIATE PRECAUTIONS
Infection Control
Dental hygienists are required to keep their practices current with infection control policies and procedures, especially in relation to
- the CDHO’s Infection Prevention and Control Guidelines (2024)
- relevant occupational health and safety legislative requirements
- relevant public health legislative requirements
- best practices or other protocols specific to the medical condition of the patient/client.
DECIDING WHEN AND WHEN NOT TO INITIATE THE PROCEDURES PROPOSED
- There is usually no contraindication to the Procedures; however, this depends on the severity and level of control of the dementia/related behavioural signs.
- With an otherwise healthy patient/client whose symptoms are under control and whose treatment is proceeding normally, the dental hygienist should implement the Procedures, though these may be postponed pending medical advice, which is likely to be required if the patient/client has
- symptoms or signs of
- behavioural or other dementia-related problems likely to cause difficulties before or during the Procedures
- comorbidity, complication or an associated condition of dementia
- thrombocytopenia, leukopenia, or agranulocytosis (i.e., excessive bleeding or significant immunosuppression), which can rarely occur with the use of antipsychotic medications
- not recently or ever sought and received medical advice relative to oral healthcare procedures
- recently changed significant medications, under medical advice or otherwise
- recently experienced changes in his/her medical condition such as medication or other side effects of treatment
- is deeply concerned about any aspect of his or her medical condition.
- symptoms or signs of
DEALING WITH ANY ADVERSE EVENTS ARISING DURING THE PROCEDURES
Dental hygienists are required to initiate emergency protocols as required by the College of Dental Hygienists of Ontario’s Standards of Practice, and as appropriate for the condition of the patient/client.
First-aid provisions and responses as required for current certification in first aid.
RECORD KEEPING
Subject to Ontario Regulation 9/08 Part III.1, Records, in particular S 12.1 (1) and (2) for a patient/client with a history of dementia, the dental hygienist should specifically record
- a summary of the medical and medications history
- any advice received from the physician/primary care provider relative to the patient/client’s condition
- the decision made by the dental hygienist, with reasons
- compliance with the precautions required
- all Procedure(s) used
- any advice given to the patient/client.
ADVISING THE PATIENT/CLIENT
The dental hygienists should
- urge the patient/client or the caregiver to alert any healthcare professional who proposes any intervention or test of
- the history of dementia
- the medications he or she is taking.
- should discuss, as appropriate
- the importance of
- checking of the mouth regularly for new signs or symptoms
- reporting to the appropriate healthcare provider any changes in the mouth
- the need for regular oral health examinations and preventive oral healthcare
- oral self-care or assisted care and provide as required information about
- choice of toothpaste
- tooth-brushing techniques and related devices
- dental flossing
- mouth rinses
- management of a dry mouth
- the importance of an appropriate diet in the maintenance of oral health
- special considerations for persons at an advanced stage of a disease or debilitation
- regimens for oral hygiene as a component of supportive care and palliative care
- the role of the family caregiver, with emphasis on maintaining an infection-free environment through hand-washing and, if appropriate, wearing gloves
- scheduling and duration of appointments to minimize stress and fatigue
- comfort level while reclining, and stress and anxiety related to the Procedures
- medication side effects such as dry mouth, and recommend treatment
- mouth ulcers and other conditions of the mouth relating to dementia, comorbidities, complications or associated conditions, medications or diet
- pain management.
- the importance of
BENEFITS/HARMS OF IMPLEMENTING THE RECOMMENDATIONS
POTENTIAL BENEFITS
- Promoting health through oral hygiene for persons who have dementia.
- Reducing the adverse effects, such as stress and fear by
- appropriately interpreting the person’s history as it pertains to dementia
- generally increasing the comfort level of persons in the course of dental hygiene interventions
- using appropriate techniques of communication
- providing advice on scheduling and duration of appointments.
- Reducing the risk that oral health needs are unmet.
POTENTIAL HARMS
- Causing adverse emotional, moods and behavioural changes.
- Performing the Procedures at an inappropriate time, such as
- when the dementia patient/client
- is likely to be alarmed or destabilized by the prospect of or application of the Procedures
- is affected or debilitated by comorbidities
- in the presence of complications for which prior medical advice is required
- in the presence of acute oral infection without prior medical advice.
- when the dementia patient/client
- Disturbing the normal dietary and medications routine of a person with dementia.
- Inappropriate management of pain or medication.
CONTRAINDICATIONS
CONTRAINDICATIONS IN REGULATIONS
Identified in the Dental Hygiene Act, 1991 – O. Reg. 218/94 Part III
ORIGINALLY DEVELOPED
2009-09-22
DATE OF LAST REVIEW
2011-07-01; 2015-06-30; 2020-05-25; 2024-06-26
ADVISORY DEVELOPER(S)
College of Dental Hygienists of Ontario, regulatory body
Greyhead Associates, medical information service specialists
SOURCE(S) OF FUNDING
College of Dental Hygienists of Ontario
ADVISORY COMITTEE
College of Dental Hygienists of Ontario, Practice Advisors
COMPOSITION OF GROUP THAT AUTHORED THE ADVISORY
Dr Gordon Atherley
O StJ , MB ChB, DIH, MD, MFCM (Royal College of Physicians, UK), FFOM (Royal College of Physicians, UK), FACOM (American College of Occupational Medicine), LLD (hc), FRSA
Dr Kevin Glasgow
MD, MBA, MHSc, DTM&H, CHE, DABPM, CCFP, FCFP, LFACHE, FACPM, FRCPC
Lisa Taylor
RDH, BA, MEd
Robert Farinaccia
RDH, BSc
Kyle Fraser
RDH, BComm, BEd, MEd
Carolle Lepage
RDH, BEd
ACKNOWLEDGEMENTS
The College of Dental Hygienists of Ontario gratefully acknowledges the Template of Guideline Attributes, on which this advisory is modelled, of The National Guideline Clearinghouse™ (NGC), sponsored by the Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services.
Denise Lalande
Final layout and proofreading
COPYRIGHT STATEMENT(S)
© 2009, 2011, 2015, 2020, 2024 College of Dental Hygienists of Ontario
FOOTNOTES
1 Persons includes young persons and children.
2 Aducanumab will be discontinued by its manufacturer in 2024. While it has received U.S. Food and Drug Administration (FDA) approval, it is not licensed in Canada.
3 At the time of this most recent update to the Advisory (June 2024), lecanemab, the first disease-modifying medication for Alzheimer disease, had been granted full approval by the FDA and is under review by Health Canada. A second such medication, donanemab, is under review by the FDA.
4 NMDA = N-methyl-D-aspartate.